Actively Recruiting
Biomarkers in Transplant Recipients to Improve Outcomes
Led by University of Pittsburgh · Updated on 2025-09-09
1200
Participants Needed
1
Research Sites
1304 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.
CONDITIONS
Official Title
Biomarkers in Transplant Recipients to Improve Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recipients of abdominal, thoracic and bone marrow allografts who are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center
- All ages
- Subject or parents are able to read and understand the informed consent
You will not qualify if you...
- Subjects and/or their parents who are unable to read and understand informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States, 15224
Actively Recruiting
Research Team
M
Morgan L Paul, BSN
CONTACT
D
Daniel Pieratt, MPA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here